Slingshot members are tracking this event:
Novartis (NVS) Announces Plans for Phase 2 Trial Assessing MorphoSys Ag's (MPSYF) Bimagrumab in Obese Patients with Type 2 Diabetes
Slingshot Insights Explained
Jan 12, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 2, Bimagrumab, Obese Patients, Type 2 Diabetes